These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20219328)

  • 41. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PAMAM-dendrimer Enhanced Antibacterial Effect of Vancomycin Hydrochloride Against Gram-Negative Bacteria.
    Serri A; Mahboubi A; Zarghi A; Moghimi HR
    J Pharm Pharm Sci; 2018; 22(1):10-21. PubMed ID: 30589641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tat-functionalized liposomes for the treatment of meningitis: an in vitro study.
    Bartomeu Garcia C; Shi D; Webster TJ
    Int J Nanomedicine; 2017; 12():3009-3021. PubMed ID: 28442909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanotransformation of Vancomycin Overcomes the Intrinsic Resistance of Gram-Negative Bacteria.
    Fernandes MM; Ivanova K; Hoyo J; Pérez-Rafael S; Francesko A; Tzanov T
    ACS Appl Mater Interfaces; 2017 May; 9(17):15022-15030. PubMed ID: 28393523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced efficacy and broadening of antibacterial action of drugs via the use of capped mesoporous nanoparticles.
    Mas N; Galiana I; Mondragón L; Aznar E; Climent E; Cabedo N; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
    Chemistry; 2013 Aug; 19(34):11167-71. PubMed ID: 23839913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhamnolipid-Based Liposomes as Promising Nano-Carriers for Enhancing the Antibacterial Activity of Peptides Derived from Bacterial Toxin-Antitoxin Systems.
    Sanches BCP; Rocha CA; Martin Bedoya JG; da Silva VL; da Silva PB; Fusco-Almeida AM; Chorilli M; Contiero J; Crusca E; Marchetto R
    Int J Nanomedicine; 2021; 16():925-939. PubMed ID: 33603360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strong antibacterial properties of anion transporters: a result of depolarization and weakening of the bacterial membrane.
    Elie CR; David G; Schmitzer AR
    J Med Chem; 2015 Mar; 58(5):2358-66. PubMed ID: 25689232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes.
    Scheeder A; Brockhoff M; Ward EN; Kaminski Schierle GS; Mela I; Kaminski CF
    J Am Chem Soc; 2023 Dec; 145(51):28240-28250. PubMed ID: 38085801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli.
    Zhou A; Kang TM; Yuan J; Beppler C; Nguyen C; Mao Z; Nguyen MQ; Yeh P; Miller JH
    Antimicrob Agents Chemother; 2015 Jan; 59(1):276-81. PubMed ID: 25348521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial Effects of Liposomes Containing Phospholipid Cardiolipin and Fluoroquinolone Levofloxacin on Mycobacterium tuberculosis with Extensive Drug Resistance.
    Gaidukevich SK; Mikulovich YL; Smirnova TG; Andreevskaya SN; Sorokoumova GM; Chernousova LN; Selishcheva AA; Shvets VI
    Bull Exp Biol Med; 2016 Mar; 160(5):675-8. PubMed ID: 27021087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
    Qi G; Li L; Yu F; Wang H
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomes- and ethosomes-associated distamycins: a comparative study.
    Cortesi R; Romagnoli R; Drechsler M; Menegatti E; Zaid AN; Ravani L; Esposito E
    J Liposome Res; 2010 Dec; 20(4):277-85. PubMed ID: 19961302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against
    Scriboni AB; Couto VM; Ribeiro LNM; Freires IA; Groppo FC; de Paula E; Franz-Montan M; Cogo-Müller K
    Front Pharmacol; 2019; 10():1401. PubMed ID: 31849660
    [No Abstract]   [Full Text] [Related]  

  • 54. Membrane-directed high bactericidal activity of (gold nanoparticle)-polythiophene composite for niche applications against pathogenic bacteria.
    Adhikari MD; Goswami S; Panda BR; Chattopadhyay A; Ramesh A
    Adv Healthc Mater; 2013 Apr; 2(4):599-606. PubMed ID: 23184755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria.
    Bai J; Yang E; Chang PS; Ryu S
    Enzyme Microb Technol; 2019 Sep; 128():40-48. PubMed ID: 31186109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomyxins: Vancomycin-Polymyxin Nonapeptide Conjugates That Retain Anti-Gram-Positive Activity with Enhanced Potency against Gram-Negative Strains.
    van Groesen E; Slingerland CJ; Innocenti P; Mihajlovic M; Masereeuw R; Martin NI
    ACS Infect Dis; 2021 Sep; 7(9):2746-2754. PubMed ID: 34387988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enterocin LD3 from Enterococcus hirae LD3 causing efflux of intracellular ions and UV-absorbing materials in Gram-negative bacteria.
    Sheoran P; Tiwari SK
    J Appl Microbiol; 2019 Apr; 126(4):1059-1069. PubMed ID: 30637906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic delivery by liposomes from prokaryotic microorganisms: Similia cum similis works better.
    Colzi I; Troyan AN; Perito B; Casalone E; Romoli R; Pieraccini G; Škalko-Basnet N; Adessi A; Rossi F; Gonnelli C; Ristori S
    Eur J Pharm Biopharm; 2015 Aug; 94():411-8. PubMed ID: 26117185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vancomycin functionalized WO
    Singh S; Moudgil A; Mishra N; Das S; Mishra P
    Biosens Bioelectron; 2019 Jul; 136():23-30. PubMed ID: 31029006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Degradation of bacterial DNA by a natural antimicrobial agent with the help of biomimetic membrane system.
    Bhandary S; Chaki S; Mukherjee S; Das S; Mukherjee S; Chaudhuri K; Dastidar SG
    Indian J Exp Biol; 2012 Jul; 50(7):491-6. PubMed ID: 22822529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.